BACE1-IN-13

Modify Date: 2024-01-28 11:04:17

BACE1-IN-13 Structure
BACE1-IN-13 structure
Common Name BACE1-IN-13
CAS Number 1397683-26-9 Molecular Weight 420.40
Density N/A Boiling Point N/A
Molecular Formula C20H17FN8O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BACE1-IN-13


BACE1-IN-13 (Compound 36) is an orally active BACE1 inhibitor with an IC50 value of 2.9 nM. BACE1-IN-13 is highly potent in hAβ42 cell (IC50 = 1.3 nM). BACE1-IN-13 has cardiovascularly safty and elicits sustained Aβ42 reduction in mouse and dog animal models[1].

 Names

Name BACE1-IN-13

 BACE1-IN-13 Biological Activity

Description BACE1-IN-13 (Compound 36) is an orally active BACE1 inhibitor with an IC50 value of 2.9 nM. BACE1-IN-13 is highly potent in hAβ42 cell (IC50 = 1.3 nM). BACE1-IN-13 has cardiovascularly safty and elicits sustained Aβ42 reduction in mouse and dog animal models[1].
Related Catalog
Target

IC50: 1.3 nM (hAβ42 cell)[1].

References

[1]. Peschiulli A, et al. A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo. ACS Med Chem Lett. 2021 Dec 1;13(1):76-83.  

 Chemical & Physical Properties

Molecular Formula C20H17FN8O2
Molecular Weight 420.40